Unlock instant, AI-driven research and patent intelligence for your innovation.

Aldo-keto reductase BcAKR, mutants thereof, and application of aldo-keto reductase BcAKR and mutants

A reductase and mutant technology, which is applied in the preparation of aldo-keto reductase BcAKR and its mutants, and the field of aldo-keto reductase BcAKR and its mutants, can solve the problems of few successful examples, and achieve improved activity and enantioselectivity. sexual effect

Active Publication Date: 2019-09-24
SHENYANG PHARMA UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, aldehydes and ketone reductases with high activity and stereoselectivity reported in the literature are still a minority.
Recently, the aldehyde and ketone reductase that exists in nature has been modified by protein engineering to improve the catalytic performance of aldehyde and ketone reductase. For example, the catalytic performance of aldehyde and ketone reductase can be improved by modifying the loop region of aldehyde and ketone reductase, but There are still few successful examples

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aldo-keto reductase BcAKR, mutants thereof, and application of aldo-keto reductase BcAKR and mutants
  • Aldo-keto reductase BcAKR, mutants thereof, and application of aldo-keto reductase BcAKR and mutants
  • Aldo-keto reductase BcAKR, mutants thereof, and application of aldo-keto reductase BcAKR and mutants

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] The extraction of embodiment 1 Bacillus cereus genomic DNA

[0053] After culturing Bacillus cereus with LB liquid overnight, centrifuge the fermentation broth in a 1mL centrifuge tube at 3000r / min for 5min, discard the supernatant to collect the cells, and repeat several times to obtain a sufficient amount of cells; b) According to the bacterial genome DNA extraction kit Instructions for the extraction of the Bacillus cereus genome.

Embodiment 2

[0054] Cloning of embodiment 2 wild-type BcAKR gene

[0055] Carry out PCR reaction with the Bacillus cereus genomic DNA obtained in Example 1 as a template, and the reaction system is as follows:

[0056]

[0057] Amplification program: 94°C: 10min, (94°C: 30s, 45°C: 30s, 72°C: 30s) 30 cycles, 72°C, 10min.

[0058] Primer 1: BcAKR-EcoR I-F: CCG GAATTC GATGAAAAAACTTACAAAGT;

[0059] Primer 2: BcAKR-Xho I-R: CCG CTCGAG GAAATCGAAGTTATCAGG;

[0060] Restriction endonuclease cut sites are underlined;

[0061] The DNA fragments amplified by PCR were purified using a gel extraction kit. E.coli DH5α containing the pET28b MBP plasmid was cultured overnight in LB liquid medium at 37°C and 220r / min, and the plasmid was extracted using the reference TIANprep Mini PlasmidKit.

[0062] The target fragment and the plasmid pET28b MBP plasmid are limited to double enzyme digestion, and the enzyme digestion system is as follows:

[0063]

[0064] The digested products were recov...

Embodiment 3E

[0065] Preparation and transformation of embodiment 3E.coli Rosetta (DE3) competent cells

[0066] a) Take 0.4mL from the seed medium and inoculate it into 20mL LB liquid medium for 3h; b) 3000r / min, enrich 2mL of bacteria in 1.5mL EP tube twice for 5min, discard the supernatant; c) add 100 μl of ice-cold TSS solution, resuspend the cells, and ice-bath for 30 minutes; d) add 20 μL of linking solution, swirl and mix gently, and ice-bath for 30 minutes; e) heat shock at 42°C for 60 seconds, ice-bath for 2 minutes, and add 600 μL of LB liquid medium. Cultivate at 37°C and shake at 150r / min for 1h; f) Take 150μL and spread them on LB resistant plates.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of biology, and relates to an aldo-keto reductase BcAKR, mutants thereof and application of the aldo-keto reductase BcAKR and the mutants. The mutants are obtained by mutation of a wild type Bacillus cereus aldo-keto reductase (BcAKR). The invention also relates to a preparation method of the aldo-keto reductase BcAKR and mutants thereof. The invention also relates to a method for obtaining an optically active S- or R-configuration secondary alcohol compound by catalyzing reduction of methyl o-chlorobenzoyl formate by the aldo-keto reductase BcAKR and the mutants thereof. The aldo-keto reductase BcAKR and the mutants thereof in the invention can catalyze the substrate to obtain an optically pure chiral alcohol, such as optically pure methyl (R)-o-chloromandelate, and have good application value in the field of chiral alcohol preparation.

Description

technical field [0001] The invention relates to the field of biotechnology, and relates to aldehyde and ketone reductase BcAKR and its mutant and application thereof. The mutant is obtained by mutation from wild-type Bacillus cereus aldo-keto reductase (BcAKR) Yes, the present invention also relates to the preparation method of the aldehyde and ketone reductase BcAKR and its mutants. It also relates to a method for obtaining optically active S or R configuration secondary alcohol compounds by catalyzing the reduction of methyl o-chlorobenzoylformate by the aldehyde and ketone reductase BcAKR and its mutants. Background technique [0002] Clopidogrel is an adenosine diphosphate (ADP) receptor blocker, which can bind to the ADP receptor on the surface of the platelet membrane, so that fibrinogen cannot bind to the glycoprotein GPⅡb / Ⅲa receptor, thereby inhibiting platelet aggregation, mainly It is used to prevent and treat heart, brain and other arterial circulation disorders...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/04C12N15/53C12N15/70C12N1/21C12P7/04C12R1/19
CPCC12N9/0006C12P7/04
Inventor 游松秦斌张文鹤祝天慧张飞霆郭继阳张瑞李衡宇
Owner SHENYANG PHARMA UNIVERSITY